Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 440

1.

Efficacies of whole cell and acellular pertussis vaccines against Bordetella parapertussis in a mouse model.

David S, van Furth R, Mooi FR.

Vaccine. 2004 May 7;22(15-16):1892-8.

PMID:
15121300
2.
3.

Protection and humoral immune responses against Bordetella pertussis infection in mice immunized with acellular or cellular pertussis immunogens.

van den Berg BM, David S, Beekhuizen H, Mooi FR, van Furth R.

Vaccine. 2000 Dec 8;19(9-10):1118-28.

PMID:
11137247
4.

Enhanced antibody response to pneumococcal polysaccharide vaccine after prior immunization with conjugate pneumococcal vaccine in HIV-infected adults.

Kroon FP, van Dissel JT, Ravensbergen E, Nibbering PH, van Furth R.

Vaccine. 2000 Nov 22;19(7-8):886-94.

PMID:
11115712
5.

Interleukin-10 has different effects on proliferation of Listeria monocytogenes in livers and spleens of mice.

Samsom JN, Annema A, Geertsma MF, Langermans JA, Groeneveld PH, de Heer E, van Furth R.

Infect Immun. 2000 Aug;68(8):4666-72.

6.

Antibody response after influenza vaccination in HIV-infected individuals: a consecutive 3-year study.

Kroon FP, van Dissel JT, de Jong JC, Zwinderman K, van Furth R.

Vaccine. 2000 Jul 1;18(26):3040-9.

PMID:
10825608
7.
8.
9.

Antibodies against pneumococcal polysaccharides after vaccination in HIV-infected individuals: 5-year follow-up of antibody concentrations.

Kroon FP, van Dissel JT, Ravensbergen E, Nibbering PH, van Furth R.

Vaccine. 1999 Oct 14;18(5-6):524-30.

PMID:
10519943
10.

Ubiquicidin, a novel murine microbicidal protein present in the cytosolic fraction of macrophages.

Hiemstra PS, van den Barselaar MT, Roest M, Nibbering PH, van Furth R.

J Leukoc Biol. 1999 Sep;66(3):423-8.

PMID:
10496312
11.

Impaired antibody response after immunization of HIV-infected individuals with the polysaccharide vaccine against Salmonella typhi (Typhim-Vi).

Kroon FP, van Dissel JT, Ravensbergen E, Nibbering PH, van Furth R.

Vaccine. 1999 Aug 6;17(23-24):2941-5.

PMID:
10462227
12.

Different effect of granulocyte colony-stimulating factor or bacterial infection on bone-marrow cells of cyclophosphamide-treated or irradiated mice.

Buisman AM, Van Zwet TL, Langermans JA, Geertsma MF, Leenen PJ, van Furth R.

Immunology. 1999 Aug;97(4):601-10.

14.

Arachidonic acid, but not its metabolites, is essential for FcgammaR-stimulated intracellular killing of Staphylococcus aureus by human monocytes.

Zheng L, Zomerdijk TP, Van Den Barselaar MT, Geertsma MF, Van Furth R, Nibbering PH.

Immunology. 1999 Jan;96(1):90-7.

15.
17.

Yops of Yersinia enterocolitica inhibit receptor-dependent superoxide anion production by human granulocytes.

Visser LG, Seijmonsbergen E, Nibbering PH, van den Broek PJ, van Furth R.

Infect Immun. 1999 Mar;67(3):1245-50.

18.

Role of Bordetella pertussis virulence factors in adherence to epithelial cell lines derived from the human respiratory tract.

van den Berg BM, Beekhuizen H, Willems RJ, Mooi FR, van Furth R.

Infect Immun. 1999 Mar;67(3):1056-62.

20.

Human monocytes and cytokines.

van Furth R.

Res Immunol. 1998 Sep-Oct;149(7-8):719-20. Review. No abstract available.

PMID:
9851530
21.
22.

Expression of adhesion molecules on granulocytes and monocytes from patients with asthma stimulated in vitro with interleukin-8 and monocyte chemotactic protein-1.

Verdegaal EM, Zegveld ST, Blokland I, Beekhuizen H, Bakker W, Willems LN, van Furth R.

Inflammation. 1998 Apr;22(2):229-42.

PMID:
9561931
23.
25.

Reduced toxoplasmastatic activity of monocytes from AIDS patients: a role for granulocyte-macrophage colony-stimulating factor.

Delemarre FG, Stevenhagen A, Kroon FP, van Furth R.

Scand J Immunol. 1998 Feb;47(2):163-6.

26.

Difference in binding of killed and live Streptococcus pneumoniae serotypes by C-reactive protein.

de Beaufort AJ, Langermans JA, Matze-van der Lans AM, Hiemstra PS, Vossen JM, van Furth R.

Scand J Immunol. 1997 Dec;46(6):597-600.

27.

Monocytes incubated with surfactant: a model for human alveolar macrophages?

Geertsma MF, Van Furth R, Nibbering PH.

J Leukoc Biol. 1997 Oct;62(4):485-92.

PMID:
9335319
28.
29.

Effect of lisofylline and pentoxifylline on the bacterial-stimulated production of TNF-alpha, IL-1 beta IL-10 by human leucocytes.

van Furth AM, Verhard-Seijmonsbergen EM, van Furth R, Langermans JA.

Immunology. 1997 Jun;91(2):193-6.

30.

Elimination of resident macrophages from the livers and spleens of immune mice impairs acquired resistance against a secondary Listeria monocytogenes infection.

Samsom JN, Annema A, Groeneveld PH, van Rooijen N, Langermans JA, van Furth R.

Infect Immun. 1997 Mar;65(3):986-93.

31.

Infection of human vascular endothelial cells with Staphylococcus aureus induces hyperadhesiveness for human monocytes and granulocytes.

Beekhuizen H, van de Gevel JS, Olsson B, van Benten IJ, van Furth R.

J Immunol. 1997 Jan 15;158(2):774-82.

PMID:
8992994
32.

Roles of proinflammatory and anti-inflammatory cytokines in pathophysiology of bacterial meningitis and effect of adjunctive therapy.

van Furth AM, Roord JJ, van Furth R.

Infect Immun. 1996 Dec;64(12):4883-90. Review. No abstract available.

33.

The effects of immunization in human immunodeficiency virus type 1 infection.

Kroon FP, Van Furth R, Bruisten SM.

N Engl J Med. 1996 Sep 12;335(11):817-8; author reply 818-9. No abstract available.

PMID:
8778589
36.

Levels of nitric oxide correlate with high levels of tumor necrosis factor alpha in cerebrospinal fluid samples from children with bacterial meningitis.

van Furth AM, Seijmonsbergen EM, Groeneveld PH, van Furth R, Langermans JA.

Clin Infect Dis. 1996 May;22(5):876-8. No abstract available.

PMID:
8722965
37.

Role of YadA in resistance to killing of Yersinia enterocolitica by antimicrobial polypeptides of human granulocytes.

Visser LG, Hiemstra PS, van den Barselaar MT, Ballieux PA, van Furth R.

Infect Immun. 1996 May;64(5):1653-8.

38.
39.

Increased production of nitric oxide correlates with viral load and activation of mononuclear phagocytes in HIV-infected patients.

Groeneveld PH, Kroon FP, Nibbering PH, Bruisten SM, van Swieten P, van Furth R.

Scand J Infect Dis. 1996;28(4):341-5.

PMID:
8893395
40.
41.
43.

Binding of FimD on Bordetella pertussis to very late antigen-5 on monocytes activates complement receptor type 3 via protein tyrosine kinases.

Hazenbos WL, van den Berg BM, Geuijen CW, Mooi FR, van Furth R.

J Immunol. 1995 Oct 15;155(8):3972-8.

PMID:
7561105
44.
46.

Role of protein kinase C isozymes in Fc gamma receptor-mediated intracellular killing of Staphylococcus aureus by human monocytes.

Zheng L, Zomerdijk TP, Aarnoudse C, van Furth R, Nibbering PH.

J Immunol. 1995 Jul 15;155(2):776-84.

PMID:
7608554
47.
48.

High levels of interleukin 10 and tumor necrosis factor alpha in cerebrospinal fluid during the onset of bacterial meningitis.

van Furth AM, Seijmonsbergen EM, Langermans JA, Groeneveld PH, de Bel CE, van Furth R.

Clin Infect Dis. 1995 Jul;21(1):220-2.

PMID:
7578738
49.

S. typhi vaccine strain Ty21a can cause a generalized infection in whole body-irradiated but not in hydrocortisone-treated mice.

Van Dissel JT, Kwappenberg K, Van Furth R.

Scand J Immunol. 1995 May;41(5):457-61.

PMID:
7725064
50.

Reduced toxoplasmastatic activity of monocytes and monocyte-derived macrophages from AIDS patients is mediated via prostaglandin E2.

Delemarre FG, Stevenhagen A, Kroon FP, van Eer MY, Meenhorst PL, van Furth R.

AIDS. 1995 May;9(5):441-5.

PMID:
7639969

Supplemental Content

Loading ...
Support Center